Related Experiment Videos
Treatment perspectives in hypertension
1Istituto di Clinica Medica e Terapia Medica, Università di Milano, Italy.
Journal of Cardiovascular Pharmacology
|January 1, 1994
Summary
Traditional hypertension trials focus on cardiovascular events, potentially underestimating benefits in mild cases. New methods assessing organ damage offer a more comprehensive evaluation of antihypertension therapy effectiveness.
Area of Science:
- Cardiology
- Clinical Trials
- Hypertension Research
Background:
- Current hypertension treatment benefit assessment relies on cardiovascular event monitoring.
- This approach has limitations in evaluating underlying vascular injury mechanisms and treatment efficacy in diverse patient groups.
Purpose of the Study:
- To highlight the limitations of event-based trials in hypertension research.
- To advocate for incorporating organ damage monitoring in hypertension trials.
- To emphasize the need for distinct evaluation criteria for preventing cardiovascular events versus organ damage.
Main Methods:
- Critique of existing event-based randomized trials in hypertension.
- Discussion of the feasibility of organ damage monitoring using new quantitative techniques.
- Conceptual framework for evaluating antihypertension therapy.
Main Results:
- Event-based trials may underestimate antihypertension therapy benefits, particularly in younger patients with mild hypertension.
- Organ damage monitoring provides a more sensitive measure of treatment benefit in these populations.
- New techniques make organ damage assessment feasible in clinical trials.
Conclusions:
- Antihypertension therapy has dual goals: preventing cardiovascular events and preventing organ damage.
- Separate trial methodologies and criteria are necessary to evaluate these distinct goals.
- Integrating organ damage assessment will improve the understanding of treatment benefits in hypertension.